AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
Carregando...
Citações na Scopus
131
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
NATURE PUBLISHING GROUP
Autores
SALPIETRO, Vincenzo
DIXON, Christine L.
GUO, Hui
BELLO, Oscar D.
VANDROVCOVA, Jana
EFTHYMIOU, Stephanie
MAROOFIAN, Reza
HEIMER, Gali
BURGLEN, Lydie
VALENCE, Stephanie
Citação
NATURE COMMUNICATIONS, v.10, article ID 3094, 16p, 2019
Resumo
AMPA receptors (AMPARs) are tetrameric ligand-gated channels made up of combinations of GluA1-4 subunits encoded by GRIA1-4 genes. GluA2 has an especially important role because, following post-transcriptional editing at the Q607 site, it renders heteromultimeric AMPARs Ca2+-impermeable, with a linear relationship between current and trans-membrane voltage. Here, we report heterozygous de novo GRIA2 mutations in 28 unrelated patients with intellectual disability (ID) and neurodevelopmental abnormalities including autism spectrum disorder (ASD), Rett syndrome-like features, and seizures or developmental epileptic encephalopathy (DEE). In functional expression studies, mutations lead to a decrease in agonist-evoked current mediated by mutant subunits compared to wild-type channels. When GluA2 subunits are co-expressed with GluA1, most GRIA2 mutations cause a decreased current amplitude and some also affect voltage rectification. Our results show that de-novo variants in GRIA2 can cause neurodevelopmental disorders, complementing evidence that other genetic causes of ID, ASD and DEE also disrupt glutamatergic synaptic transmission.
Palavras-chave
Referências
- Achuta VS, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan8784
- Asrar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004339
- Barbon A, 2011, BIOCHEMISTRY-MOSCOW+, V76, P882, DOI 10.1134/S0006297911080037
- Brechet A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15910
- BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677
- Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420
- Carvill GL, 2013, NAT GENET, V45, P1073, DOI 10.1038/ng.2727
- Chen SW, 2018, NAT GENET, V50, P1032, DOI 10.1038/s41588-018-0130-z
- Coutelier M, 2015, NEUROLOGY, V84, P1751, DOI 10.1212/WNL.0000000000001524
- Davies B, 2017, HUM MOL GENET, V26, P3869, DOI 10.1093/hmg/ddx270
- Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324
- Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
- Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677
- Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x
- Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010
- Geisheker MR, 2017, NAT NEUROSCI, V20, P1043, DOI 10.1038/nn.4589
- Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8
- Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
- Hackmann K, 2013, EUR J HUM GENET, V21, P112, DOI 10.1038/ejhg.2012.97
- Hagberg Bengt, 2002, Eur J Paediatr Neurol, V6, P293, DOI 10.1053/ejpn.2002.0612
- Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001
- Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b
- Heyne HO, 2018, NAT GENET, V50, P1048, DOI 10.1038/s41588-018-0143-7
- Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001
- Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1
- Kury S, 2017, AM J HUM GENET, V101, P768, DOI 10.1016/j.ajhg.2017.10.003
- Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z
- Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450
- Lee SC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-54
- Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
- Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728
- Li RH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006129
- Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711
- Liu SJ, 2012, J PHYSIOL-LONDON, V590, P13, DOI 10.1113/jphysiol.2011.213926
- Lombardi LM, 2015, J CLIN INVEST, V125, P2914, DOI 10.1172/JCI78167
- Martin S, 2017, AM J HUM GENET, V101, P1013, DOI 10.1016/j.ajhg.2017.11.004
- Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062
- Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603
- Morimura N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15800
- Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124
- Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055
- Sadybekov A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00472-0
- Salazar H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14327
- Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217
- Schalock R., 2010, INTELLECTUAL DISABIL
- Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709
- Sobolevsky AI, 2005, BIOPHYS J, V88, P235, DOI 10.1529/biophysj.104.049411
- Sobolevsky AI, 2015, J PHYSIOL-LONDON, V593, P29, DOI 10.1113/jphysiol.2013.264911
- Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624
- Srivastava S, 2018, NEUROGENETICS, V19, P41, DOI 10.1007/s10048-017-0535-3
- Sukumaran M, 2011, EMBO J, V30, P972, DOI 10.1038/emboj.2011.17
- Tanaka AJ, 2015, AM J HUM GENET, V97, P457, DOI 10.1016/j.ajhg.2015.07.014
- Tramarin M, 2018, HUM MOL GENET, V27, P2052, DOI 10.1093/hmg/ddy108
- Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451
- Twomey EC, 2018, NEURON, V99, P956, DOI 10.1016/j.neuron.2018.07.027
- Twomey EC, 2017, NATURE, V549, P60, DOI 10.1038/nature23479
- Twomey EC, 2016, SCIENCE, V353, P83, DOI 10.1126/science.aaf8411
- Van Damme P, 2005, J NEUROPATH EXP NEUR, V64, P605, DOI 10.1097/01.jnen.0000171647.09589.07
- Vidal S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11620-3
- Vissers LELM, 2016, NAT REV GENET, V17, P9, DOI 10.1038/nrg3999
- Wang J, 2018, NAT COMMUN, V9, P1
- Wang TY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13316
- Wu Y, 2007, P NATL ACAD SCI USA, V104, P18163, DOI 10.1073/pnas.0708699104
- Yoo Y, 2017, ANN NEUROL, V82, P466, DOI 10.1002/ana.25032
- Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009